Literature DB >> 19474399

Null retinoschisin-protein expression from an RS1 c354del1-ins18 mutation causing progressive and severe XLRS in a cross-sectional family study.

Camasamudram Vijayasarathy1, Lucia Ziccardi, Yong Zeng, Nizar Smaoui, Rafael C Caruso, Paul A Sieving.   

Abstract

PURPOSE: To explore the retinoschisin (RS1) protein biochemical phenotype from an RS1 exon-5 deletion/insertion frame-shift mutation in a family with X-linked retinoschisis (XLRS) and describe the clinical and electrophysiological features.
METHODS: Six XLRS males underwent ophthalmic examination and electroretinogram (ERG) recording. The RS1 gene was sequenced. Mutant RS1-RNA and protein expression were assessed by transfecting COS-7 cells with minigene constructs.
RESULTS: All six males carried the RS1 c354del1-ins18 mutation in which an 18-bp insertion replaced nucleotide 354, duplicating the adjacent upstream intron 4-to-exon 5 junction and creating a premature termination codon downstream. Analysis indicated normal pre-mRNA splicing producing mRNA transcripts. Truncated RS1 protein was expressed transiently but was degraded rapidly by a proteasomal pathway rather than by nonsense-mediated mRNA decay. Two boys, 1.5 and 5 years of age, had foveal cysts and minimal peripheral schisis, and retained near-normal scotopic b-wave amplitude and normal ERG waveforms. The 5-year-old's ERG was diminished when repeated 3 years later. Four older XLRS relatives 32 to 45 years old had substantial b-wave loss and strongly electronegative ERGs; three had overt macular atrophy. Cross-sectional family analysis showed the b-/a-wave amplitude ratio as inversely related to age in the six males.
CONCLUSIONS: The c354del1-ins18 mutation caused an RS1-null biochemical phenotype and a progressive clinical phenotype in a 5-year-old boy, whereas the older XLRS relatives had macular atrophy and marked ERG changes. The phenotypic heterogeneity with age by cross-sectional study of this family mutation argues that XLRS disease is not stationary and raises questions regarding factors involved in progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474399      PMCID: PMC2784021          DOI: 10.1167/iovs.09-3839

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  First molecular evidence for a de novo mutation in RS1 (XLRS1) associated with X linked juvenile retinoschisis.

Authors:  A Gehrig; B H Weber; B Lorenz; M Andrassi
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

2.  Congenital X-linked retinoschisis classification system.

Authors:  Jonathan L Prenner; Antonio Capone; Stefano Ciaccia; Yuichiro Takada; Paul A Sieving; Michael T Trese
Journal:  Retina       Date:  2006-09       Impact factor: 4.256

3.  X-linked retinoschisis: novel mutation in the initiation codon of the XLRS1 gene in a large family.

Authors:  David Y Kim; Kimberly A Neely; Joseph W Sassani; Tamara R Vrabec; Avinash Tantri; Arcilee Frost; Larry A Donoso
Journal:  Retina       Date:  2006-10       Impact factor: 4.256

4.  Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery.

Authors:  Yuichiro Takada; Camasamudram Vijayasarathy; Yong Zeng; Sten Kjellstrom; Ronald A Bush; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08       Impact factor: 4.799

5.  Degradation of C-terminal truncated alpha A-crystallins by the ubiquitin-proteasome pathway.

Authors:  Xinyu Zhang; Edward J Dudek; Bingfen Liu; Linlin Ding; Alexandre F Fernandes; Jack J Liang; Joseph Horwitz; Allen Taylor; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

6.  Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration.

Authors:  Sten Kjellstrom; Ronald A Bush; Yong Zeng; Yuichiro Takada; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

7.  Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis.

Authors:  N Z Gregori; A M Berrocal; G Gregori; T G Murray; R W Knighton; H W Flynn; S Dubovy; C A Puliafito; P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2008-11-19       Impact factor: 4.638

8.  Genetic modification of the schisis phenotype in a mouse model of X-linked retinoschisis.

Authors:  Britt A Johnson; Natsuyo Aoyama; Nicole H Friedell; Sakae Ikeda; Akihiro Ikeda
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

9.  Truncation of retinoschisin protein associated with a novel splice site mutation in the RS1 gene.

Authors:  Balázs Lesch; Viktória Szabó; Melinda Kánya; Balázs Varsányi; Gábor M Somfai; János Hargitai; Rita Vámos; Orsolya Fiedler; Agnes Farkas
Journal:  Mol Vis       Date:  2008-08-25       Impact factor: 2.367

10.  Clinical and genetic findings in Hungarian patients with X-linked juvenile retinoschisis.

Authors:  B Lesch; V Szabó; M Kánya; G M Somfai; R Vámos; B Varsányi; Zs Pámer; K Knézy; Gy Salacz; M Janáky; M Ferencz; J Hargitai; A Papp; A Farkas
Journal:  Mol Vis       Date:  2008-12-12       Impact factor: 2.367

View more
  10 in total

1.  Retinoschisin (RS1) interacts with negatively charged lipid bilayers in the presence of Ca2+: an atomic force microscopy study.

Authors:  Svetlana Kotova; Camasamudram Vijayasarathy; Emilios K Dimitriadis; Laertis Ikonomou; Howard Jaffe; Paul A Sieving
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

2.  Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.

Authors:  Catherine Cukras; Henry E Wiley; Brett G Jeffrey; H Nida Sen; Amy Turriff; Yong Zeng; Camasamudram Vijayasarathy; Dario Marangoni; Lucia Ziccardi; Sten Kjellstrom; Tae Kwon Park; Suja Hiriyanna; J Fraser Wright; Peter Colosi; Zhijian Wu; Ronald A Bush; Lisa L Wei; Paul A Sieving
Journal:  Mol Ther       Date:  2018-07-07       Impact factor: 11.454

3.  X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects.

Authors:  Kristen Bowles; Catherine Cukras; Amy Turriff; Yuri Sergeev; Susan Vitale; Ronald A Bush; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

4.  Phenotypic expression of X-linked retinoschisis in Chinese families with mutations in the RS1 gene.

Authors:  Fei Xu; Hang Xiang; Ruxin Jiang; Fangtian Dong; Ruifang Sui
Journal:  Doc Ophthalmol       Date:  2011-06-24       Impact factor: 2.379

Review 5.  Biology of retinoschisin.

Authors:  Camasamudram Vijayasarathy; Lucia Ziccardi; Paul A Sieving
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer.

Authors:  Jingxing Ou; Camasamudram Vijayasarathy; Lucia Ziccardi; Shan Chen; Yong Zeng; Dario Marangoni; Jodie G Pope; Ronald A Bush; Zhijian Wu; Wei Li; Paul A Sieving
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

7.  Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.

Authors:  Camasamudram Vijayasarathy; Ruifang Sui; Yong Zeng; Guoxing Yang; Fei Xu; Rafael C Caruso; Richard A Lewis; Lucia Ziccardi; Paul A Sieving
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

8.  Test-Retest Intervisit Variability of Functional and Structural Parameters in X-Linked Retinoschisis.

Authors:  Brett G Jeffrey; Catherine A Cukras; Susan Vitale; Amy Turriff; Kristin Bowles; Paul A Sieving
Journal:  Transl Vis Sci Technol       Date:  2014-10-03       Impact factor: 3.283

9.  Understanding variable disease severity in X-linked retinoschisis: Does RS1 secretory mechanism determine disease severity?

Authors:  Dhandayuthapani Sudha; Srividya Neriyanuri; Ramya Sachidanandam; Srikrupa N Natarajan; Mamatha Gandra; Arokiasamy Tharigopala; Muthukumaran Sivashanmugam; Mohammed Alameen; Umashankar Vetrivel; Lingam Gopal; Vikas Khetan; Rajiv Raman; Parveen Sen; Subbulakshmi Chidambaram; Jayamuruga Pandian Arunachalam
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

10.  Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population.

Authors:  Bohdan Kousal; Lucia Hlavata; Hana Vlaskova; Lenka Dvorakova; Michaela Brichova; Zora Dubska; Hana Langrova; Andrea L Vincent; Lubica Dudakova; Petra Liskova
Journal:  Genes (Basel)       Date:  2021-11-18       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.